跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
捷扶康 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Elvitegravir, Cobicistat, Emtricitabine and Tenofovir Alafenamide Fumarate Tablets
Approved
化学药品
Elvitegravir, Cobicistat, Emtricitabine and Tenofovir Alafenamide Fumarate Tablets
GILEAD SCIENCES IRELAND UC
🇨🇳 National Medical Products Administration
Approval Date
Feb 14, 2023
Approval ID
1xpZqfU4lME
Company
GILEAD SCIENCES IRELAND UC
Type
化学药品
Approval Details
Approval Id
1xpZqfU4lME
Approval Number
国药准字HJ20180043
Generic Name
艾考恩丙替片
Generic Name En
Elvitegravir, Cobicistat, Emtricitabine and Tenofovir Alafenamide Fumarate Tablets
Trade Name
捷扶康
Drug Type
化学药品
Dosage Form
片剂
Strength
每片含150mg艾维雷韦,150mg考比司他,200mg恩曲他滨和10mg丙酚替诺福韦
Reg Date
2023-02-14
Expired Date
2028-02-13
Company Name
GILEAD SCIENCES IRELAND UC
Production Company Name
Patheon Inc
Company Detail Path
/organization/gilead-sciences-ireland-uc
Production Company Detail Path
/organization/patheon-inc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Feb 14, 2023
Approval ID
1xpZqfU4lME
Type
化学药品
Back to NMPA Approvals